A detailed history of Wealth Architects, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Wealth Architects, LLC holds 2,916 shares of NVO stock, worth $415,150. This represents 0.05% of its overall portfolio holdings.

Number of Shares
2,916
Previous 3,149 7.4%
Holding current value
$415,150
Previous $325,000 15.08%
% of portfolio
0.05%
Previous 0.05%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $23,791 - $31,669
-233 Reduced 7.4%
2,916 $374,000
Q4 2023

Feb 14, 2024

BUY
$87.78 - $105.45 $4,125 - $4,956
47 Added 1.52%
3,149 $325,000
Q3 2023

Nov 09, 2023

BUY
$90.94 - $199.54 $142,593 - $312,878
1,568 Added 102.22%
3,102 $282,000
Q2 2023

Aug 02, 2023

BUY
$155.98 - $172.65 $467 - $517
3 Added 0.2%
1,534 $248,000
Q1 2023

Apr 21, 2023

BUY
$132.34 - $159.14 $5,161 - $6,206
39 Added 2.61%
1,531 $243,000
Q4 2022

Feb 09, 2023

BUY
$102.55 - $135.33 $153,004 - $201,912
1,492 New
1,492 $201,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $321B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wealth Architects, LLC Portfolio

Follow Wealth Architects, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Architects, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Architects, LLC with notifications on news.